A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
A RCT Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
1 other identifier
interventional
95
1 country
1
Brief Summary
The study, entitled "RCT study of laparoscopic middle hepatic venous guidance versus conventional ananatomical hemihepatectomy", was designed to compare the efficacy of two different ananatomical hemihepatectomy procedures under laparoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hepatocellular-carcinoma
Started Dec 2019
Typical duration for not_applicable hepatocellular-carcinoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 23, 2019
CompletedFirst Submitted
Initial submission to the registry
May 20, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2023
CompletedDecember 26, 2023
December 1, 2023
4 years
May 20, 2020
December 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival rate
follow-up after the surgery every 3 months, to understand statistics 1-year overall survival、3-year overall survival、1-year disease-free survival、3-year disease-free survival
3 years
Secondary Outcomes (2)
Perioperative results
Duration perioperation(an expected average of 3 days)
intraoperative parameters
during the operation
Other Outcomes (1)
Incidence of postoperative complications
Duration hospitalization(an expected average of 7 days)
Study Arms (2)
laparoscopic middle hepatic vein guidance hemihepatectomy
EXPERIMENTALIn theory, the advantages of anatomical hemihepatectomy guided by middle hepatic vein are as follows: 1) correctly guiding the transecting plane of the liver parenchyma can reduce the cross-sectional area of the liver and avoid damaging the vascular ducts of the pre-cut liver. so as to reduce the residue of necrotic tissue without blood supply and reduce the occurrence of postoperative complications. 2) active anatomy and exposure of hepatic vein can avoid uncontrollable bleeding after passive injury of hepatic vein, and laparoscopic anatomy has obvious advantage in exposing hepatic vein. 3) it may reduce the early recurrence rate of hepatocellular carcinoma after operation.
laparoscopic traditional anatomic hemihepatectomy
ACTIVE COMPARATORAccording to textbooks and the views of some scholars at present, traditional anatomical hepatectomy (non-hepatic vein-guided anatomical hepatectomy) has the following advantages: 1) avoiding exposure of hepatic vein can reduce the probability of injury to the trunk of hepatic vein, thus reduce the risk of massive bleeding during operation; 2) the difficulty of operation is relatively low, and a better short-term and long-term effect can be obtained.
Interventions
95 patients with primary HCC were divided into the middle hepatic vein guidance group(n=45) and the traditional group(n=45) according to the odd and even Numbers, and sealed into envelopes.Outcomes were monitored and evaluated during the 3-year follow-up period
Eligibility Criteria
You may qualify if:
- the site was limited to the patients who were suitable for dissecting hemihepatectomy;
- the type of disease was limited to hepatocellular carcinoma;
- the patients were generally able to tolerate anesthesia, the liver reserve function was good, and the patients were suitable for laparoscopic surgery;
- child-pugh grade A, no severe liver cirrhosis, portal hypertension, no extrahepatic and extrahepatic metastasis and main vascular invasion;
- the subjects who participated in this study indicated that they were willing to accept the two surgical methods and agreed to be randomly divided into groups during the operation;
- ≤ age ≤ 70, male or female.
You may not qualify if:
- preoperative liver function Child-pugh grade B or C;
- patients with poor general condition and could not tolerate pneumoperitoneum or anesthesia;
- patients with severe liver cirrhosis, portal hypertension and lesions invading liver porta;
- patients with other treatment methods such as radio frequency ablation in addition to dissecting hepatectomy;
- repeated abdominal operations resulting in severe abdominal adhesion, unable to perform laparoscopic hepatectomy; male and female are not limited
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southwest Hospital
Chongqing, Chongqing Municipality, 400038, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Two different treatments are conducted on the participant base on the randomized choices
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Hepatobiliary Surgery Institute; Chief Physician; Administrator of laparoscopic department
Study Record Dates
First Submitted
May 20, 2020
First Posted
June 9, 2020
Study Start
December 23, 2019
Primary Completion
December 23, 2023
Study Completion
December 23, 2023
Last Updated
December 26, 2023
Record last verified: 2023-12